Is AFC-HD AMS Life Science stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, AFC-HD AMS Life Science pays dividends. Last time was Friday 1st of November 2024 where the investors holding the stock on Thursday 29th of August 2024 were paid JPY15 per share. Over the last 33 times between 2005 and 2024, AFC-HD AMS Life Science has paid JPY537.5 with an average of JPY16.29 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for AFC-HD AMS Life Science 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY644.00, you would have made a profit of JPY163.00 per share or 25.31%
Yes, the average daily trading liquidity for AFC-HD AMS Life Science is JPY41 880 thousand. You should therefore be able to get in and out of your positions relatively fast.
AFC-HD AMS Life Science has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.07, the company's ability to pay off the debt is limited. The company has a very low net profit margin of 4.81%, which is challenging.
We have calculated the inflation risk for AFC-HD AMS Life Science to be medium [0.65 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.